Novel Proteasome Activators That Enhance MHC Class I Antigen Presentation and Trigger Anti-Myeloma T-Cell Immunity
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
multiple myeloma (MM), HDAC6 inhibitor, proteasome, MHC class I antigen, immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要